Viewing Study NCT07235202


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-01-12 @ 11:20 AM
Study NCT ID: NCT07235202
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2025-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
Sponsor: Shenzhen Majory Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module